Camber intros theophylline extended-release tablets
Theophylline ER tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.
Camber is releasing theophylline extended-release tablets.
Theophylline extended-release tablets are indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases.
Camber Pharmaceuticals rolls out generic Invega
Camber's theophylline extended-release tablets are available in 300 mg and 450 mg strengths, both in 100-ct. bottles.